AUDIO ONLY - Impact on Prior Art and Patent Eligibility

This is an audio-only, downloadable recording of the webinar described below.

At issue in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. was whether the sale of an invention to a third party, who is obligated to keep the invention confidential, may place the invention "on sale" for purposes of the America Invents Act (AIA). In a unanimous decision, the Court held that such sales qualify as prior art under the AIA. The Court left open what the phrase "otherwise available to the public" is intended to cover but ruled that it did not alter the meaning of prior art established pre-AIA. The ruling's impact on patent eligibility is expected to be a major factor in future court cases and Patent Trial and Appeal Board proceedings.

This webinar will discuss on-sale and public use bars, prior art rulings under both AIA and pre-AIA law, and how you can minimize risk of patent infringement and invalidity claims.